Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
SRI-011381
Cat. No.:
OB0225LY-0212
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
SRI-011381 is a compound with a specific biological target that affects cell function and proliferation.
Synonym:
1629138-41-5; SRI011381; 1-Benzyl-3-cyclohexyl-1-(piperidin-4-ylmethyl)urea; N'-Cyclohexyl-N-(phenylmethyl)-N-(4-piperidinylmethyl)-urea; 1-Benzyl-3-cyclohexyl-1-[(piperidin-4-yl)methyl]urea
CAS No.:
1629138-41-5
Compound CID:
77050694
Formula:
C20H31N3O
Formula Weight:
329.48
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
SRI-011381 can be used for the study of cell proliferation and apoptosis.
Library Information
Targets:
TGF-beta/Smad
Receptors:
TGF-β receptor
Pathways:
Stem cells
Plate Number:
AOCL-3
Plate Location:
f6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 166.93 mM
